Paclitaxel-eluting biodegradable synthetic vascular prostheses a step towards reduction of neointima formation?

Circulation

Volumn 120, Issue SUPPL. 1, 2009, Pages

  Innocente, Francesco ^a,b,c   Mandracchia, Delia ^d   Pektok, Erman ^e   Nottelet, Benjamin ^d   Tille, Jean Christophe ^a   De Valence, Sarra ^d   Faggian, Giuseppe ^b   Mazzucco, Alessandro ^b   Kalangos, Afksendiyos ^a   Gurny, Robert ^d   Moeller, Michael ^d   Walpoth, Beat H ^a,f  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF VERONA   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e YEDITEPE UNIVERSITY   (Turkey)

^f Clinical and Experimental   (Switzerland)

Author keywords

Coronary disease; Endothelium; Intimal hyperplasia; Paclitaxel elution; Vascular prostheses

Indexed keywords

NANOFIBER; PACLITAXEL; POLYCAPROLACTONE; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STENOSIS; TISSUE REACTION; TREATMENT OUTCOME; ANIMAL; BIOMECHANICS; BLOOD; CELL PROLIFERATION; CHEMISTRY; HYPERPLASIA; INTIMA; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOMECHANICS; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; HYPERPLASIA; MALE; PACLITAXEL; POLYESTERS; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA;

EID: 70349782432     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.848242     Document Type: Article

References (24)

1. Ounpuu S, Anand S, Yusuf S. The impending global epidemic of cardiovascular diseases. Eur Heart J. 2000;21:880-883. (Pubitemid 30307415)
2. Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg. 2002;23:475-485. (Pubitemid 41079396)
3. Pawlowski KJ, Rittgers SE, Schmidt SP, Bowlin GL. Endothelial cell seeding of polymeric vascular grafts. Frontiers Biosci. 2004;9: 1412-1421. (Pubitemid 39060853)
4. Nottelet B, Pektok E, Mandracchia D, Tille JC, Walpoth B, Gurny R, Möller M. Factorial design optimization and in vivo feasibility of poly(scaprolactone)- micro- and nanofiber-based small diameter vascular grafts. J Biomed Mater Res A. 2009;89:865-875.
5. Pektok E, Nottelet B, Tille JC, Gurny R, Kalangos A, Moeller M, Walpoth B. Degradation and healing characteristics of small-diameter poly(s-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation, 2008;118:2563-2570.
6. Nair LS, Laurencin CT. Biodegradable polymers as biomaterials. Prog Polym Sci. 2007;32:762-798.
7. Hong MK, Komowski R, Bramwell O, Ragheb AO, Leon MB. Paclitaxelcoated Gianturco-Roubin (R) IIA1 (GR (R) II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coronary Artery Dis. 2001;12:513-515.
8. Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Juni P, Pfisterer ME, Meier B, Kastrati A. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with, coronary artery disease. J Am Coll Cardiol. 2007;50:1373-1380. (Pubitemid 47449734)
9. Zeng J, Xu X, Chen X, Liang Q, Bian X, Yang L, Jing X. Biodegradable electrospun fibers for drug delivery. J Control. Release. 2003 ;92:227-231. (Pubitemid 38366145)
10. Xie J, Wang CH. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharmaceut Res. 2006;23:1817-1826. (Pubitemid 44200545)
11. Walpoth BH, Cikirikcioglu M, Mugnai D, Tille JC, Pektok E, Pfister R, Palombo D, Kalangos A, Bowlin G. Biodegradable small calibre polydioxanone-based vascular prostheses: Potential as coronary bypass grafts. Circulation. 2007;116:11-444. Abstract.
12. Lee SJ, Liu J, Oh SH, Soker S, Atala A, Yoo JJ. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials. 2008;29:2891-2898.
13. Drachman DE, Edelman ER, Seifert P, Groothuis AR, Bornstein DA, Kamath KR, Palasis M, Yang DC, Nott SH, Rogers C. Neointimal thickening after stent delivery of paclitaxel: Change in composition, and arrest of growth over six months. J Am Coll. Cardiol. 2000;36:2325-2332.
14. Liu J, Meisner D, Kwong E, Wu XY, Johnston MR. A novel translymphatic drug delivery system.: Implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials. 2007;28:3236-3244. (Pubitemid 46654215)
15. Zeng J, Yang L, Liang Q, Zhang X, Guan H, Xu X, Chen X, Jing X, Influence of the drug compatibility with polymer solution on. the release kinetics of electrospun. fiber formulation. J Control Release. 2005;105: 43-51. (Pubitemid 40805474)
16. Clerin V, Nichol JW, Petko M, Myung RJ, Gaynor JW, Gooch KJ. Tissue engineering of arteries by directed remodeling of intact arterial segments. Tissue. Eng. 2003;9:461-472. (Pubitemid 36736129)
17. Cerqueira NF, Yoshida WB, Müller SS, Sequeira JL, de Castro Rodrigues A, Padovani CR. Morphological and biomechanical study of abdominal aorta of rats submitted to experimental chronic alcoholism. Acta Cir Brasil. 2005;20:213-218.
18. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerekens U, Russell ME. Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42. (Pubitemid 36070930)
19. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drugeluting stents. J Am Coll Cardiol. 2008;52:333-342. (Pubitemid 352001347)
20. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998-1008. (Pubitemid 46376800)
21. Walpoth BH, Pavlicek M, Celik B, Nicolaus B, Schaffner T, Althaus U, Hess OM, Carrel T, Morris RE. Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. Eur J Cardiothorac Surg. 2001;19:487-492. (Pubitemid 32297781)
22. Schachner T, Zou Y, Oberhuber A, Tzankov A, Mairinger T, Laufer G, Bonatti JO. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann. Thorac Surg. 2004;77:1580-1585. (Pubitemid 38529985)
23. Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT study. J Am Coll. Cardiol, 2006;48:2432-2439.
24. Daemen J, Ong AT, Stefanini GG, Tsuchida K, Spindler H, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW. Three-year clinical follow-up of the unrestricted use of sirolumus-eluting stents as part of the Rapamycin-Eluting Stent evaluated at Rotterdam. Cardiology Hospital (RESEARCH) registry. Am J Cardiol. 2006;98:895-901. (Pubitemid 44402258)